Navigation Links
Lentigen Appoints Jim Meade as Vice President of Corporate Development
Date:6/16/2008

BALTIMORE, June 16 /PRNewswire/ -- Lentigen Corporation today announced the appointment of Jim Meade, Ph.D., CLP, as vice president of corporate development. In addition to contributing to the strategic direction of the company, Dr. Meade will be responsible for managing the development of Lentigen's partnerships, stakeholder relations, product and intellectual property portfolios, contract negotiations, and other key aspects of corporate development.

Tim Ravenscroft, CEO of Lentigen, commented, "Jim's extensive background in strategic development, opportunity evaluation, and negotiation will be an important asset to Lentigen as we continue to advance our business opportunities and collaborative relationships in biotherapeutics, vaccines and protein production."

Dr. Meade previously worked at Avalon Pharmaceuticals, where he served as vice president of business development. With more than 30 years' experience in the pharmaceutical and biotechnology industries, he has also held senior-level positions at Pharmacia, Bayer and Chiron. He holds a Ph.D. in molecular biology from the University of Texas, and is a Certified Licensing Professional and an active member of the Licensing Executives Society.

About Lentigen Corporation

Lentigen Corporation is a privately owned biotechnology company focused on the development of lentiviral vector technology for a wide range of therapeutic, vaccine, and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, co-developing lentiviral vector-based products across a broad spectrum of bench to clinical applications. Partnerships include The National Institutes of Health, The University of Pennsylvania, ThermoFisher Scientific and The U.S. Army. For further information, visit http://www.lentigen.com.

Contact:

Gregory Tiberend

gtiberend@rlcinc.com

Meghan Feeks

mfeeks@rlcinc.com

Richard Lewis Communications, Inc.

212-827-0020


'/>"/>
SOURCE Lentigen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
2. Lentigen Licenses Fundamental Lentiviral Vector Technology Patent From the University of Cambridge
3. Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer
4. Lentigen to Move Headquarters and Manufacturing to Gaithersburg
5. Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
6. VIRxSYS and Lentigen Announce Litigation Settlement
7. NovaVision Appoints Medical Technology Veteran Rudy Mazzocchi as Chief Executive Officer
8. Applied Computational Technologies Appoints a New CEO
9. AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs
10. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
11. American Oriental Bioengineering Appoints Anindya Chatterjee to Chief Strategy Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... SANTA BARBARA, CALIFORNIA (PRWEB) , ... September 18, ... ... risk management, technological innovation and business process optimization firm for the life sciences ... presentation at the ServiceMax Maximize 2017 conference. , What: Digital Transformation in Medical ...
(Date:9/14/2017)... ... September 14, 2017 , ... RoosterBio ... clinically-relevant starting and ancillary materials that generate unprecedented efficiencies in adult stem ... The CliniControl product portfolio will radically simplify major steps in product development ...
(Date:9/14/2017)... ... September 14, 2017 , ... ... analytics solutions, today announced that its Anzo Smart Data Lake has been named ... includes technologies and solutions that help organizations succeed in surpassing their knowledge management ...
(Date:9/12/2017)... ... September 12, 2017 , ... ... has announced the release of their latest product LabCODE™, a novel Lab ... LabCODE™ offers pre-built capabilities for Biobanking, Pharmacokinetics, Pharmacogenetics, Next Generation Sequencing, ...
Breaking Biology Technology:
(Date:6/30/2017)... Va. , June 30, 2017 ... leading developer and supplier of face and eye ... ATA Featured Product provider program. ... an innovative way to monitor a driver,s attentiveness ... greatly from being able to detect fatigue and ...
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at ... between startups and global businesses, taking place in ... startups will showcase the solutions they have built with IBM ... France is one of the most ... increase in the number of startups created between 2012 and ...
(Date:5/16/2017)... 2017  Veratad Technologies, LLC ( www.veratad.com ), an ... identity verification solutions, announced today they will participate as ... 15 thru May 17, 2017, in Washington ... Center. Identity impacts the lives of ... quickly evolving digital world, defining identity is critical to ...
Breaking Biology News(10 mins):